menu search

ACAD / Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up

Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up
Acadia (ACAD) reports better-than-expected third-quarter 2023 results as both earnings and sales beat estimates. The stock rises in after-market hours. Read More
Posted: Nov 3 2023, 09:48
Author Name: Zacks Investment Research
Views: 030166

ACAD News  

Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up

By Zacks Investment Research
November 3, 2023

Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up

Acadia (ACAD) reports better-than-expected third-quarter 2023 results as both earnings and sales beat estimates. The stock rises in after-market hours more_horizontal

ACADIA Pharmaceuticals Inc. (ACAD) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 3, 2023

ACADIA Pharmaceuticals Inc. (ACAD) Q3 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Jessica Tieszen - Associa more_horizontal

Reasons to Add Acadia (ACAD) Stock to Your Portfolio Now

By Zacks Investment Research
October 12, 2023

Reasons to Add Acadia (ACAD) Stock to Your Portfolio Now

Here we discuss some reasons why investing in Acadia (ACAD) stock now may turn out to be a more prudent move than ever. more_horizontal

2 Growth Stocks I'd Buy on the Dip

By The Motley Fool
September 30, 2023

2 Growth Stocks I'd Buy on the Dip

September hasn't been overly kind to growth stocks. This latest bout of volatility, however, may have created some compelling buying opportunities. more_horizontal

Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?

By Zacks Investment Research
September 28, 2023

Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?

Acadia (ACAD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions more_horizontal

Acadia stock price analysis: ACAD risk/reward is attractive

By Invezz
September 27, 2023

Acadia stock price analysis: ACAD risk/reward is attractive

Acadia Pharmaceuticals (NASDAQ: ACAD) stock price did well on Wednesday even as American equities retreated. The biotech stock jumped to a high of $26 more_horizontal

Acadia Pharmaceuticals: Difficult Market Masks Progress

By Seeking Alpha
September 26, 2023

Acadia Pharmaceuticals: Difficult Market Masks Progress

Acadia Pharmaceuticals' gains recently disappeared despite the strong launch of Daybue. Poor market conditions are to blame, especially the poor biote more_horizontal

Daybue Drives Acadia Pharmaceuticals To Positive Earnings (Rating Upgrade)

By Seeking Alpha
September 23, 2023

Daybue Drives Acadia Pharmaceuticals To Positive Earnings (Rating Upgrade)

Acadia Pharmaceuticals shows fiscal resilience with a shift to net positive income, buoyed by Daybue's strong Q2 debut and increased Nuplazid sales. D more_horizontal


Search within

Pages Search Results: